ArticleBMJ open ophthalmology2019

Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial.

Beatriz González-Rodríguez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.